Cite
HARVARD Citation
Caocci, G. et al. (2019). Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real‐life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart. Hematological oncology. 37 (3), pp. 296-302. [Online].